ClearBridge Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
ClearBridge Investments's MDGL Position: Q3 2026 in Review
ClearBridge Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 15% in Q3 2026, buying an estimated $8.69M and bringing the position to 125,764 shares worth $63.4M. The position accounts for 0.05% of the portfolio, ranked #279.
ClearBridge Investments first reported a position in MDGL in Q1 2026 and has held it in 3 quarters since. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- ClearBridge Investments held 125,764 shares of Madrigal Pharmaceuticals worth $63.4M as of Q3 2026.
- ClearBridge Investments bought 16,439 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $8.69M.
- Madrigal Pharmaceuticals made up 0.05% of ClearBridge Investments's portfolio in Q3 2026, its #279 holding.
- ClearBridge Investments first reported a position in Madrigal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on ClearBridge Investments's 13F filing for Q3 2026, filed 12 Nov 2026.